Provided by Tiger Trade Technology Pte. Ltd.

crane

201.86
+4.332.19%
Volume:122.03K
Turnover:24.59M
Market Cap:11.63B
PE:35.23
High:206.58
Open:202.88
Low:199.62
Close:197.53
52wk High:230.50
52wk Low:159.58
Shares:57.60M
Float Shares:48.76M
Volume Ratio:0.61
T/O Rate:0.25%
Dividend:1.00
Dividend Rate:0.49%
EPS(TTM):5.73
EPS(LYR):6.26
ROE:16.52%
ROA:12.73%
PB:5.34
PE(LYR):32.27

Loading ...

CR Double-Crane Pharma Gets China Registration for Brain Surgery Irrigation Solution

MT Newswires Live
·
Sep 09

E KOCREF CR-REIT Receives Clean Audit Opinions and Posts Stable Earnings

TIPRANKS
·
Sep 08

Crane Director James L. L. Tullis Disposes of 400 Shares Worth $82,150

Reuters
·
Sep 03

CR Sanjiu Gets Registration Approval for 1 Billion Yuan Bonds

MT Newswires Live
·
Sep 02

Crane : Deutsche Bank Cuts Target Price to $240 from $248

THOMSON REUTERS
·
Sep 01

CR Double-Crane Pharma Gets Registration Certificate for Oxcarbazepine Tablets

MT Newswires Live
·
Sep 01

U.S. Research Roundup-Autodesk, Hubspot, Oracle

Reuters
·
Sep 01

E KOCREF CR-REIT Seeks Proxies Ahead of AGM as It Maintains High Dividend Payouts

TIPRANKS
·
Sep 01

CR Mixc Lifestyle's Cash Flow, Expected Dividend Growth Reinforces Core Holding Status

Dow Jones
·
Aug 31

Stronger-Than-Expected Q2 Results And Higher EPS Guidance Might Change The Case For Investing In Crane (CR)

Simply Wall St.
·
Aug 29

Press Release: InnoCare Reports 2026 Interim Results, Sustained Profitability and Key Milestones Achieved

Dow Jones
·
Aug 24

Press Release: Antengene Announces 2026 Interim Results: Achieves First

Dow Jones
·
Aug 24

UroGen Submits NDA for UGN-103, an Investigational Treatment of Recurrent LG-IR-NMIBC

GlobeNewswire
·
Aug 17

Crane Director James L. L. Tullis Sells 614 Shares for $138,150

Reuters
·
Aug 15

Press Release: Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 15

Press Release: Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 15

Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial

GlobeNewswire
·
Aug 14

Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 14

What Crane (CR)'s Acquisition-Fueled Guidance Hike Means For Shareholders

Simply Wall St.
·
Aug 10

UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights

GlobeNewswire
·
Aug 05